CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Louisville, Kentucky, United States and 48 other locations
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Louisville, Kentucky, United States and 46 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Louisville, Kentucky, United States and 209 other locations
medicinal product\]) in patients with advanced or metastasized non-small cell lung cancer (NSCLC) and...
Phase 1
Louisville, Kentucky, United States and 37 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Louisville, Kentucky, United States and 126 other locations
participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....
Phase 1, Phase 2
Louisville, Kentucky, United States and 9 other locations
"study drugs". The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The...
Phase 2
Louisville, Kentucky, United States and 54 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Louisville, Kentucky, United States and 238 other locations
of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...
Phase 3
Louisville, Kentucky, United States and 168 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Louisville, Kentucky, United States and 252 other locations
Clinical trials
Research sites
Resources
Legal